ROIV

Roivant Sciences
D

ROIV

Arincen25/100B
40.640
USD
-0.02
(-0.05%)
Market Open
Last updated: · Delayed 15 min
Q2 FY2027 results
EPS-0.27+26.4%Revenue35.12M+710.0%
OverviewFinancialsForecastEarningsCompany

Roivant Sciences shares outstanding 2019–2026

Roivant Sciences had 722,323,015 shares outstanding on 10 November 2026. Roivant Sciences had 738.17M diluted shares on average over the last twelve months, up 5.8% on the twelve months before. In fiscal year 2025 the average was 693.86M.

Last updated 10 Nov 2026 · Next report 5 Feb 2027

Shares outstanding

Change on the year

Fiscal yearPeriod endingShares outstandingChange on the yearBasic shares
TTM30 Sept 2026738.17M+5.78%710.63M
FY202531 Mar 2026693.86M-4.35%693.86M
FY202431 Mar 2025725.40M-12.71%725.40M
FY202331 Mar 2024831.05M+16.59%783.25M
FY202231 Mar 2023712.79M+6.43%712.79M
FY202131 Mar 2022669.75M-2.20%669.75M
FY202031 Mar 2021684.79M0.00%684.79M
FY201931 Mar 2020684.79M—684.79M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Roivant Sciences's shares

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.